[go: up one dir, main page]

Epigallocatechin gallate (EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line, Caco-2

Biol Pharm Bull. 2001 Sep;24(9):1076-8. doi: 10.1248/bpb.24.1076.

Abstract

We have previously reported that epigallocatechin gallate (EGCG) strongly inhibits the in vitro phenol sulfotransferase (P-ST) activity of a human colon carcinoma cell line, Caco-2. In the present study, we examined the ability of EGCG to inhibit the sulfation of 1-naphthol in intact Caco-2 cells. Sulfation of 1-naphthol was detected in Caco-2 cells after 2 h of incubation, and was observed to continue for 24 h, resulting in an accumulation of sulfated 1-naphthol. Sulfation was strongly inhibited by the addition of EGCG to the culture medium. The IC50 of EGCG was calculated to be 20 microM; this value is similar to that obtained from in vitro assays (14 microM) [Ref. Tamura et al., Biol. Pharm. Bull., 23, 695, (2000)]. These results indicate that catechins are capable of inhibiting P-ST activity in intact cells as well as in vitro. We believe that the inhibitory activity of catechins might be the mechanism by which catechins (and green tea) exert anti-carcinogenic activity against procarcinogenic compounds that require P-ST activation in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Arylsulfotransferase / antagonists & inhibitors
  • Caco-2 Cells
  • Catechin / analogs & derivatives
  • Catechin / pharmacology*
  • Chromatography, High Pressure Liquid
  • Depression, Chemical
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Naphthols / metabolism*
  • Sulfates / metabolism*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Naphthols
  • Sulfates
  • 1-naphthol
  • Catechin
  • epigallocatechin gallate
  • Arylsulfotransferase